Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
AU 2024384453
CITRATE COORDINATION COMPLEX OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF
granted -
PT 3886798
COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF
granted -
US 20260083736
GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS FOR USE IN THE TREATMENT OF SUBSTANCE USE DISORDER IN PATIENTS WITH HIGH IMPULSIVITY
granted -
US 20260060930
New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases
granted -
US 20260055120
Bicyclic pyrimidinones as inhibitors of NOX4
granted -
US 20260008777
INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
granted -
US 20260001878
SUBSTITUTED PYRROLOPYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF TLR9
granted -
US 2025333394
Tiparp Inhibitor Compounds
granted -
EP 4640274
LPAR1-INHIBITOREN
granted -
US 2025304535
KAT6 Inhibitors
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12428379
Acylsulfonamide KAT6A inhibitors
granted -
US 12428395
Heterocyclic compounds as kinase inhibitor and uses thereof
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted -
US 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12421273
Ectonucleotidase inhibitors and methods of use thereof
granted -
US 12421253
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12421269
SGLT2/DPP4 inhibitor and application thereof
granted -
US 12421228
Naphthyridine derivatives as PRC2 inhibitors
granted -
US 12421249
Inhibitors of APOL1 and methods of using same
granted -
US 12414981
JNK inhibitors for use in treating and preventing neurodegenerative disorders
granted